Tanggot, Juven A.
HRN: 28-61-22 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
AMPICILLIN 250MG (VIAL)
02/18/2026
02/25/2026
IV
190MG
Q12H
PCAP
Checking Initial Appropriateness
02/20/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/20/2026
02/27/2026
IV
50mg
Q24h
PCAP C
Checking Initial Appropriateness
02/28/2026
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/28/2026
03/07/2026
PO
1mL
BID
PCAP
Checking Initial Appropriateness
03/06/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/06/2026
03/13/2026
IV
45mg LD; 23mg MD
Q24
Sepsis
Checking Initial Appropriateness
03/12/2026
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
03/12/2026
03/16/2026
VIA OGT
40mg On Day 1; 20mg On Day 2-5
OD
PCAP-D
Checking Initial Appropriateness
03/15/2026
CEFTAZIDIME 1GM (VIAL)
03/15/2026
03/22/2026
IV DRIP
190mg
Q8
Pcap D T/c Vap
Checking Initial Appropriateness
03/15/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/15/2026
03/22/2026
IV DRIP
250mg
Q6
Pcap D T/c Vap
Checking Initial Appropriateness
03/17/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/17/2026
03/24/2026
IV
30mg
Q12H
T/C VHAP
Checking Initial Appropriateness